This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 05:17, 12 August 2011 (Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per [[Misplaced Pages:WikiProject Chemicals/Chembox validation|Chem/Drugbox). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 05:17, 12 August 2011 by CheMoBot (talk | contribs) (Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per [[Misplaced Pages:WikiProject Chemicals/Chembox validation|Chem/Drugbox)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compoundClinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C14H14N4O2 |
Molar mass | 270.28 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
(verify) |
Razobazam (INN) is a drug which is a benzodiazepine derivative. Its mechanism of action appears to be quite different from that of most benzodiazepine drugs, and it produces nootropic effects in animal studies.
See also
References
- Hock FJ, Scheich H. Functional activity in the brain of socially deprivated rats produced by an active avoidance test after razobazam (Hoe 175) treatment: a 2-deoxyglucose study. Behavioural and Neural Biology. 1986 Nov;46(3):398-409. PMID 3814045
This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |